On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...